Juel CTB, Lund A, Andersen MM, Hansen CP, et al. The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial. Diabetologia 2020 May 11. pii: 10.1007/s00125-020-05158.
PMID: 32394228